Andrew Saik - 31 Dec 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
EVP & Chief Financial Officer
Signature
/s/ Rocco Venezia
Issuer symbol
N/A
Transactions as of
31 Dec 2022
Net transactions value
-$8,882
Form type
4
Filing time
03 Jan 2023, 15:04:22 UTC
Previous filing
23 Dec 2022
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $8,882 -718 -1.3% $12.37 56,290 31 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.